1,738
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs

, , , , , & show all
Pages 872-877 | Received 10 Mar 2014, Accepted 29 Apr 2014, Published online: 28 May 2014

References

  • Baum GL, Lafair J. (2003). DOTS-S: directly observed therapy short course-with smiles. Int J Tuberc Lung Dis 7:200–1
  • Doan TV, Olivier JC. (2009). Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization. Int J Pharm 382:61–6
  • Duret C, Wauthoz N, Merlos R, et al. (2012). In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice. Eur J Pharm Biopharm 81:627–34
  • Gangotri W, Jain-Raina R, Babbar SB. (2012). Evaluation of guar gum derivatives as gelling agents for microbial culture media. World J Microbiol Biotechnol 28:2279–85
  • Garg T, Singh O, Arora S, Murthy R. (2012). Scaffold: a novel carrier for cell and drug delivery. Crit Rev Ther Drug Carrier Syst 29:1–63
  • Garg T, Singh S, Goyal AK. (2013). Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery. Crit Rev Ther Drug Carrier Syst 30:369–409
  • Goyal G, Garg T, Malik B, et al. (2013). Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug delivery
  • Hirota K, Hasegawa T, Nakajima T, et al. (2010). Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis. J Control Release 142:339–46
  • Islam N, Gladki E. (2008). Dry powder inhalers (DPIs) – a review of device reliability and innovation. Int J Pharm 360:1–11
  • Kaur M, Garg T, Rath G, Goyal AK. (2014a). Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis. Crit Rev Ther Drug Carrier Syst 31:49–88
  • Kaur M, Malik B, Garg T, et al. (2014b). Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug delivery
  • Misra A, Hickey AJ, Rossi C, et al. (2011). Inhaled drug therapy for treatment of tuberculosis. Tuberculosis (Edinb) 91:71–81
  • Parnami N, Garg T, Rath G, Goyal AK. (2013). Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy. Artif Cells Nanomed Biotechnol
  • Shim TS, Jo KW. (2013). Medical treatment of pulmonary multidrug-resistant tuberculosis. Infect Chemother 45:367–74
  • Singh H, Sharma R, Joshi M, et al. (2014). Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artif Cells Nanomed Biotechnol. [Epub ahead of print]
  • Soumya RS, Ghosh S, Abraham ET. (2010). Preparation and characterization of guar gum nanoparticles. Int J Biol Macromol 46:267–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.